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 Abstract 
The exponentially growing human population and the emergence of new diseases are 
clear indications that the world can no longer depend solely on conventional vaccine 
technologies and production schemes. The race to find a new vaccine technology is 
crucial to help speed up and complement the World Health Organization (WHO) disease 
elimination program. The ultimate goal is to uncover fast and efficient production 
schemes in the event of a pandemic, and also to effectively fight deadly diseases such 
as malaria, bird flu, hepatitis, and human immunodeficiency virus (HIV). Plasmid DNA 
vaccines, if properly formulated, offer specific priming of the immune system and 
similar or even better prophylactic effects than conventional vaccines. This article 
discusses many of the critical issues that need to be considered when developing fast, 
effective, and reliable plasmid DNA vaccine manufacturing processes. Different modes 
of plasmid production via bacterial fermentation are compared. Plasmid purification by 
chromatography is specifically discussed as it is the most commercially viable bioprocess 
engineering technique for continuous purification of supercoiled plasmid DNA. Current 
techniques and progress covering the area of plasmid DNA vaccine design, formulation, 
and delivery are also put forward. 
